These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 18651546)

  • 81. Intravenous pulse cyclophosphamide and steroids induce immunological and clinical remission in New-incident and relapsing primary membranous nephropathy.
    Kanigicherla DAK; Hamilton P; Czapla K; Brenchley PE
    Nephrology (Carlton); 2018 Jan; 23(1):60-68. PubMed ID: 27778424
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Takayasu arteritis in children: preliminary experience with cyclophosphamide induction and corticosteroids followed by methotrexate.
    Ozen S; Duzova A; Bakkaloglu A; Bilginer Y; Cil BE; Demircin M; Davin JC; Bakkaloğlu M
    J Pediatr; 2007 Jan; 150(1):72-6. PubMed ID: 17188618
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Therapeutic strategy combining intravenous cyclophosphamide followed by oral azathioprine to treat worsening interstitial lung disease associated with systemic sclerosis: a retrospective multicenter open-label study.
    Bérezné A; Ranque B; Valeyre D; Brauner M; Allanore Y; Launay D; Le Guern V; Kahn JE; Couderc LJ; Constans J; Cohen P; Mahr A; Pagnoux C; Hachulla E; Kahan A; Cabane J; Guillevin L; Mouthon L
    J Rheumatol; 2008 Jun; 35(6):1064-72. PubMed ID: 18464307
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Synchronised therapy and high-dose cyclophosphamide in proliferative lupus nephritis.
    Danieli MG; Palmieri C; Salvi A; Refe MC; Strusi AS; Danieli G
    J Clin Apher; 2002; 17(2):72-7. PubMed ID: 12210709
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Behcet's disease and IgA nephropathy: report of this association in a patient from Brazil and literature review.
    Fernandes PF; Júnior GB; Barros FA; Sousa DC; Franco LM; Patrocínio RM
    Invest Clin; 2006 Dec; 47(4):405-11. PubMed ID: 17176908
    [TBL] [Abstract][Full Text] [Related]  

  • 86. [Treatment of membranous nephropathy with chronic renal insufficiency].
    Passerini P; Leoni A
    G Ital Nefrol; 2008; 25 Suppl 44():76-82. PubMed ID: 19048590
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial.
    Cattran DC; Appel GB; Hebert LA; Hunsicker LG; Pohl MA; Hoy WE; Maxwell DR; Kunis CL;
    Kidney Int; 2001 Apr; 59(4):1484-90. PubMed ID: 11260412
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Does treatment with corticosteroids and cyclosporine reduce transglutaminase type 2 expression in the renal tissue of patients with membranous nephropathy?
    Papasotiriou M; Kalliakmani P; Huang L; Gerolymos M; Goumenos DS; Johnson TS
    Nephron Clin Pract; 2012; 121(1-2):c60-7. PubMed ID: 23107829
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Pulse cyclophosphamide inadequately suppresses reoccurrence of minimal change nephrotic syndrome in corticoid-dependent children.
    Donia AF; Gazareen SH; Ahmed HA; Moustafa FE; Shoeib AA; Ismail AM; Khamis S; Sobh MA
    Nephrol Dial Transplant; 2003 Oct; 18(10):2054-8. PubMed ID: 13679480
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Upregulation of antiphospholipid antibodies following cyclophosphamide therapy in patients with systemic lupus erythematosus.
    Vlachoyiannopoulos PG; Toya SP; Katsifis G; Zintzaras E; Tzioufas AG; Moutsopoulos HM
    J Rheumatol; 2008 Sep; 35(9):1768-75. PubMed ID: 18634157
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Randomized controlled trial of cyclophosphamide, warfarin and dipyridamole in idiopathic membranous glomerulonephritis.
    Murphy BF; McDonald I; Fairley KF; Kincaid-Smith PS
    Clin Nephrol; 1992 May; 37(5):229-34. PubMed ID: 1606772
    [TBL] [Abstract][Full Text] [Related]  

  • 92. [Treatment of idiopathic membranous nephropathy. Is the anti-CD20 antibody rituximab a reasonable option?].
    Busch M; Gerth J; Ott U; Schip A; Haufe CC; Gröne HJ; Wolf G
    Med Klin (Munich); 2008 Jul; 103(7):519-24. PubMed ID: 18604487
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Low-dose cyclosporine treatment in Chinese nephrotic patients with idiopathic membranous nephropathy: An uncontrolled study with prospective follow-up.
    Li J; Zhang YM; Qu Z; Zhao MH; Liu G
    Am J Med Sci; 2010 Jun; 339(6):532-6. PubMed ID: 20442650
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Effectiveness and safety of cyclophosphamide or tacrolimus therapy for idiopathic membranous nephropathy.
    Zou H; Jiang F; Xu G
    Intern Med J; 2020 May; 50(5):612-619. PubMed ID: 31389094
    [TBL] [Abstract][Full Text] [Related]  

  • 95. [Clinical course in 51 patients with idiopathic membranous glomerulopathy].
    Ardiles L; Mezzano S; Arriagada A; Caorsi I
    Rev Med Chil; 1989 Mar; 117(3):266-72. PubMed ID: 2488518
    [TBL] [Abstract][Full Text] [Related]  

  • 96. A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years.
    Moroni G; Doria A; Mosca M; Alberighi OD; Ferraccioli G; Todesco S; Manno C; Altieri P; Ferrara R; Greco S; Ponticelli C
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):925-32. PubMed ID: 17699309
    [TBL] [Abstract][Full Text] [Related]  

  • 97. [Therapy of lupus nephritis with standard therapeutic protocols and cyclosporine].
    Petrović R; Stojanović R; Novicić-Sasić D; Dimitrijević J; Pavlović S; Stojković D; Palić-Obradović D; Stevanović G; Prodanović S
    Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():13-8. PubMed ID: 12583308
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Conservative versus immunosuppressive treatment of patients with idiopathic membranous nephropathy.
    Torres A; Domínguez-Gil B; Carreño A; Hernández E; Morales E; Segura J; González E; Praga M
    Kidney Int; 2002 Jan; 61(1):219-27. PubMed ID: 11786104
    [TBL] [Abstract][Full Text] [Related]  

  • 99. [Cyclophosphamide pulse therapy in patients with primary glomerulonephritis].
    Rutkowski B; Wielgosz A; Manitius J; Bułło B; Kowalewska J; Tylicki L; Roszkiewicz A
    Przegl Lek; 2000; 57(11):624-7. PubMed ID: 11293209
    [TBL] [Abstract][Full Text] [Related]  

  • 100. A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy.
    Woodle ES; First MR; Pirsch J; Shihab F; Gaber AO; Van Veldhuisen P;
    Ann Surg; 2008 Oct; 248(4):564-77. PubMed ID: 18936569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.